Recipharm

We had an incredible time at #CPHIMilan, filled with engaging discussions, insightful meetings, invaluable networking and teambuilding! 🤝🎉 Our team had the pleasure of connecting with many of you, sharing ideas 💡, and exploring new opportunities to shape the future of the pharmaceutical industry. 🙌 Looking forward to continuing the conversations and building on the momentum! 🚀 https://lnkd.in/dfU6pRjv #Recipharm #PharmaInnovation #TeamBuilding #CPHI2024 #Networking

CPHI Day 2 is complete - a successful and busy day for the whole team. If you still want to meet, come by booth #7B2 - we look forward to meeting with you. #OneExtraordinaryCDMO #CPHIMilan

All set for CPHI Milan, welcome to our booth #7B2 🎉. We can’t wait to meet you 🤝😊!   #CPHI #PharmaNetworking #PharmaceuticalSolutions #Recipharm #IndustryLeaders #HealthcareTransformation #PharmaIndustry 

📢Announcing ReciBioPharm’s partnership with LenioBio, driving innovation in cell-free protein production for rapid vaccine development! 🌍

Recipharm continues to expand its pharmaceutical development capabilities with strategic investments across key areas: 🚀 - Expanded Oral Solid Dosage (OSD), Sterile Fill & Finish (SFF) product development capabilities - New labs for sterile liquids and lyophilised products, plus advanced GMP pilot scale equipment for BFS, PFS, and vials - Enhanced analytical labs for Extractables & Leachables, Nitrosamines, and Elemental Impurities - Supporting all phases of product development from API route scouting to commercial manufacturing! With cutting-edge technologies, teams of experts across our sites and a global footprint, we’re pushing innovation forward and helping to deliver life-saving medicines. 💊🌟 Learn more about how we’re reshaping pharmaceutical development at Recipharm! https://lnkd.in/g5fHK32S #PharmaInnovation #PharmaceuticalDevelopment #Recipharm #OSD #SterileFillFinish #AnalyticalServices #Biologics #ATMPs #Pharma

With our unique platform ReciPredict we solve complex problems in product development, tech-transfer, and routine manufacturing in an efficient and reliable way. 💡🔬 ReciPredict optimises pharmaceutical development, tech-transfer and life cycle management by merging the Recipharm expertise with state-of-the-art material sciences, process sciences, and data sciences with small scale, pilot scale and full scale GMP equipment into an integrated platform. In our latest factsheet we explain how you can accelerate your project timeline, reduce API consumption and fully understand your materials and processes with our unique platform. Intrigued? Read our latest factsheet here: https://lnkd.in/d9UXYshP #TechTransfer #Pharmadevelopment #OSD #FillFinish

🚀 The Countdown to CPHI Milan begins! 🚀 Less than a week to go until CPHI Milan, and we’re busy making the final preparations! 🙌 Our team is excited to welcome you to booth #7B2, where we’ll be ready to connect and discuss how Recipharm can support your pharmaceutical projects.   Whether you're looking to explore new opportunities, connect with our experts, or just stop by for a chat, we can’t wait to meet you and learn more about your goals. 💡   Stay tuned for live updates and insights from the exhibition – it’s going to be an event you don’t want to miss! 👀   👉 Mark your calendar: 🗓️ October 8-10 📍 Booth #7B2 See you in Milan! 🌟https://lnkd.in/d5XA3fYD   #CPHI #PharmaNetworking #PharmaceuticalSolutions #Recipharm #IndustryLeaders #CDMO 

🌟With proven track record we are a partner you can trust. Our advanced lyophilisation services, backed by decades of experience, offer superior freeze-drying technology ❄️, fast and efficient sterile fill & finish solutions, and a seamless transition from development to production—all under one roof! 🏢 Learn more: https://lnkd.in/d5heVNBM #lyophilization #FillFinish #Sterilefilling #CDMO

🚨We are proud to share that Recipharm has formed an exclusive strategic alliance with Exela Pharma Sciences LLC , to advance our sterile manufacturing capabilities in the US. This partnership represents a significant step forward in our mission to deliver high-quality, scalable and innovative solutions to the global biopharmaceutical industry. 🌍💊 Through access to Exela’s FDA-accredited, state-of-the-art facility in Lenoir, North Carolina, we can now offer over 100 million units of production capacity, including vials and pre-filled syringes (PFS). This alliance is designed to accelerate growth in key areas such as GLP-1 drugs, oncology therapies and other complex biologics including Antibody Drug Conjugates (ADCs), driving innovation in high-demand, sterile products. 🔬🚀 Strategic benefits: ✅ Expanded US footprint with the capability to serve both domestic and international markets. ✅ Advanced automation technologies, including visual inspection and auto-injector assembly, ensuring precision and efficiency. ✅ Enhanced regulatory compliance, maintaining FDA and international quality standards to meet the needs of a growing, global biopharma market. ✅ Strong synergies in rapid tech transfer, positioning us to meet customer demands with unmatched speed and scalability. This partnership reflects our long-term commitment to supporting the evolving needs of our clients, providing seamless solutions for scaling complex pharmaceuticals and positioning Recipharm as a leader in sterile manufacturing on a global scale. 🌐 As we continue to innovate and expand, this strategic collaboration with Exela opens up new pathways for delivering cutting-edge therapies across the pharmaceutical landscape. Together, we’re building a stronger future for healthcare innovation. 💡💪 Stay connected as we embark on this exciting new chapter! https://lnkd.in/d_n4WHUJ #SterileManufacturing #GlobalPharmaPartnership #HealthcareInnovation 

ReciBioPharm’s innovative approach to ATMP services is transforming the future of medicine! Don’t miss out—follow ReciBioPharm today! 👇